Cellectis S.A. Files Routine 6-K Report
Ticker: CLLS · Form: 6-K · Filed: Apr 28, 2025 · CIK: 1627281
Sentiment: neutral
Topics: sec-filing, 6-k, reporting
TL;DR
Cellectis filed a 6-K, just a routine update, no big news here.
AI Summary
Cellectis S.A. filed a Form 6-K on April 28, 2025, to report information for the month of April 2025. The company, a biopharmaceutical firm based in Paris, France, indicated it files annual reports under Form 20-F. This filing does not contain specific financial figures or operational updates beyond its routine reporting status.
Why It Matters
This filing confirms Cellectis's ongoing compliance with SEC reporting requirements as a foreign private issuer. It signals no immediate material changes but maintains transparency for investors.
Risk Assessment
Risk Level: low — The filing is a standard procedural report and does not contain any new material information that would inherently increase risk.
Key Players & Entities
- Cellectis S.A. (company) — Filer of the report
- April 2025 (date) — Reporting period
- 20250428 (date) — Filing date
- 001-36891 (other) — SEC file number
- 8 RUE DE LA CROIX JARRY (address) — Principal executive office and mailing address
- PARIS, LLE-DE-FRANCE (location) — City and region of principal executive office
FAQ
What is the purpose of this Form 6-K filing by Cellectis S.A.?
The Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of April 2025.
When was this Form 6-K filed with the SEC?
The filing date, as indicated by the accession number and header information, is April 28, 2025.
Does Cellectis S.A. file annual reports under Form 20-F or 40-F?
Cellectis S.A. indicates by check mark that it files annual reports under cover of Form 20-F.
What is the principal executive office address for Cellectis S.A.?
The principal executive office is located at 8, rue de la Croix Jarry, 75013 Paris, France.
Is Cellectis S.A. submitting this Form 6-K in paper format?
The filing does not explicitly state it is submitting in paper format; it only includes check boxes for the possibility under Regulation S-T Rule 101(b)(1).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 28, 2025 regarding Cellectis S.A. (CLLS).